Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.


Intracranial Gliomas Part III - Innovative Treatment Modalities

Editor(s): Chernov M.F. (Tokyo) 
Muragaki Y. (Tokyo) 
Kesari S. (Santa Monica, Calif.) 
McCutcheon I.E. (Houston, Tex.) 

Status: in preparation (to be released approx. 03/31/2018)
Publication year: 2018
Buy this book
Print Version: CHF 200.00, EUR 187.00, USD 235.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.

This book belongs to
Progress in Neurological Surgery , Vol. 32
Editor(s): Lunsford L.D. (Pittsburgh, Pa.) 
approx. XII + 240 p., 38 fig., 30 in color, 19 tab., hard cover, 2018
Status: in preparation (to be released approx. 03/31/2018)   
ISSN: 0079-6492
e-ISSN: 1662-3924

A review of novel therapeutic modalities
At present most intracranial gliomas are considered incurable with current treatment strategies, and the search for new modalities that may effectively control tumor growth continues. The chapters in this volume describe basic principles and therapeutic possibilities of several innovative techniques, including photodynamic therapy, laser-induced interstitial thermotherapy, stereotactic cryodestruction, high-intensity focused ultrasound ablation, boron neutron capture therapy, proton and carbon ion irradiation, targeted therapy, immunotherapy, gene therapy, local chemotherapy, and alternating electric fields therapy. Potential applications of extracellular vesicles and nanotechnology for management of gliomas are highlighted as well. Many of these methods have already demonstrated antitumor efficacy in clinical testing, whereas others are still under development.
The materials presented in this book are mainly directed at clinicians treating patients with brain tumors, as well as clinical and basic researchers working in the field of neuro-oncology.